Table 2.
Clinical results of select kinase inhibitors in CLL
AE indicates adverse event; URI, upper respiratory tract infection; LFT, liver function test; RA, rheumatoid arthritis; NHL, non-Hodgkin lymphoma; and MCL, mantle cell lymphoma
*IWCLL criteria.60
